Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using same
US-2022211680-A1 · Jul 7, 2022 · US
Schlesinger Larry is listed as an inventor on 9 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Schlesinger Larry |
| Total patents | 9 |
| First publication | Sep 17, 2015 |
| Latest publication | Jul 7, 2022 |
Publications ranked by popularity score, then publication date.
US-2022211680-A1 · Jul 7, 2022 · US
US-10806803-B2 · Oct 20, 2020 · US
US-10028933-B2 · Jul 24, 2018 · US
US-2017209584-A1 · Jul 27, 2017 · US
US-2017202969-A1 · Jul 20, 2017 · US
US-2017020846-A1 · Jan 26, 2017 · US
US-9457031-B2 · Oct 4, 2016 · US
US-2016213647-A1 · Jul 28, 2016 · US
US-2015258100-A1 · Sep 17, 2015 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ohio State Innovation Foundation | 7 |
| Cardinal Health 414 Llc | 2 |
| Schlesinger Larry | 2 |
| Cope Fred | 2 |
| Navidea Biopharmaceuticals Inc | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/415 | 5 |
| A61K45/06 | 5 |
| A61K49/0054 | 4 |
| A61K47/61 | 4 |
| A61K31/4409 | 4 |